Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD +4.84%14 EV-to-EBIT is 39.27 as of Sep. 15, 2026, which is 144% above its 10-year median of 16.11. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 482 Healthcare Providers & Services companies, Vijaypd Ceutical ranks worse than 83.4% on this metric.
The historical rank and industry rank for Vijaypd Ceutical's EV-to-EBIT or its related term are showing as below:
NSE:VIJAYPD'
s EV-to-EBIT Range Over the Past 10 Years
Min: 11.49 Med: 16.11 Max: 39.27
Current: 39.27
During the past 4 years, the highest EV-to-EBIT of Vijaypd Ceutical was 39.27. The lowest was 11.49. And the median was 16.11.
NSE:VIJAYPD's EV-to-EBIT is ranked worse than 83.4% of 482
companies
in the Healthcare Providers & Services industry
Industry Median: 14.965
vs NSE:VIJAYPD: 39.27
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Vijaypd Ceutical's Enterprise Value for the quarter that ended in Mar. 2026 was ₹1,464.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vijaypd Ceutical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹37.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaypd Ceutical EV-to-EBIT Related Terms
Vijaypd Ceutical EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaypd Ceutical EV-to-EBIT Chart
Vijaypd Ceutical Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
EV-to-EBIT
0.00
0.00
0.00
18.02
Vijaypd Ceutical Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
EV-to-EBIT
0.00
0.00
0.00
18.02
Vijaypd Ceutical EV-to-EBIT Competitor Comparison
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's EV-to-EBIT falls into.
Vijaypd Ceutical's current Enterprise Value is ₹1,460.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vijaypd Ceutical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹37.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaypd Ceutical (NSE:VIJAYPD) has a EV-to-EBIT of 39.27 as of Sep. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vijaypd Ceutical and its competitors. This is 144% above median its historical median of 16.11. Over the past decade, Vijaypd Ceutical's EV-to-EBIT has ranged from 11.49 to 39.27. According to the industry distribution chart, Vijaypd Ceutical ranks #402 out of 482 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Vijaypd Ceutical's EV-to-EBIT too high?
Vijaypd Ceutical's current EV-to-EBIT of 39.27 is 144% above median its 10-year median of 16.11. Over the past 10 years, this metric has ranged from a low of 11.49 to a high of 39.27. The Healthcare Providers & Services industry median EV-to-EBIT is 14.97. Vijaypd Ceutical's value of 39.27 is 162.4% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #402 out of 482 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Vijaypd Ceutical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #402 out of 482 companies for EV-to-EBIT. This places Vijaypd Ceutical in the lower half of its industry. The industry median EV-to-EBIT is 14.97. Vijaypd Ceutical's value of 39.27 is 162.4% above this benchmark. Historically, Vijaypd Ceutical's own EV-to-EBIT has ranged from 11.49 to 39.27 over the past decade. While the company's 10-year median is 16.11 vs. the industry median of 14.97, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 14.97, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current EV-to-EBIT of 39.27 is 162.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 14.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current EV-to-EBIT is 39.27, which is 144% above median its own 10-year median of 16.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current EV-to-EBIT of 39.27. The current EV-to-EBIT is 39.27, which is 144% above median its 10-year median of 16.11 and 162.4% above the Healthcare Providers & Services industry median of 14.97. Vijaypd Ceutical's overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current EV-to-EBIT is 39.27 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
14GF Score
Get the complete analysis for NSE:VIJAYPD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
